纳米载体的制备与大分子药物递送：挑战与机遇
Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.
作者信息
Agrahari Vibhuti, Agrahari Vivek, Mitra Ashim K
机构信息
Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, HSB 5258, 2464 Charlotte St, Kansas City, MO 64108, USA.
出版信息
Ther Deliv. 2016;7(4):257-78. doi: 10.4155/tde-2015-0012.
Abstract
Macromolecules (proteins/peptides) have the potential for the development of new therapeutics. Due to their specific mechanism of action, macromolecules can be administered at relatively low doses compared with small-molecule drugs. Unfortunately, the therapeutic potential and clinical application of macromolecules is hampered by various obstacles including their large size, short in vivo half-life, phagocytic clearance, poor membrane permeability and structural instability. These challenges have encouraged researchers to develop novel strategies for effective delivery of macromolecules. In this review, various routes of macromolecule administration (invasive/noninvasive) are discussed. The advantages/limitations of novel delivery systems and the potential role of nanotechnology for the delivery of macromolecules are elaborated. In addition, fabrication approaches to make nanoformulations in different shapes and sizes are also summarized.
摘要
大分子（蛋白质/肽）具有开发新型疗法的潜力。由于其特定的作用机制，与小分子药物相比，大分子可以以相对较低的剂量给药。不幸的是，大分子的治疗潜力和临床应用受到各种障碍的阻碍，包括其体积大、体内半衰期短、吞噬清除、膜通透性差和结构不稳定。这些挑战促使研究人员开发有效的大分子递送新策略。在这篇综述中，讨论了大分子给药的各种途径（侵入性/非侵入性）。阐述了新型递送系统的优点/局限性以及纳米技术在大分子递送中的潜在作用。此外，还总结了制备不同形状和尺寸纳米制剂的方法。
相似文献
1
Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.纳米载体的制备与大分子药物递送：挑战与机遇
Ther Deliv. 2016;7(4):257-78. doi: 10.4155/tde-2015-0012.
2
Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery.脂质体、微粒和纳米粒在蛋白质和肽类药物传递中的最新进展。
Peptides. 2010 Jan;31(1):184-93. doi: 10.1016/j.peptides.2009.10.002. Epub 2009 Oct 9.
3
Polysaccharide-based micro/nanohydrogels for delivering macromolecular therapeutics.多糖基微/纳米水凝胶用于递送高分子治疗药物。
J Control Release. 2014 Nov 10;193:162-73. doi: 10.1016/j.jconrel.2014.05.014. Epub 2014 May 17.
4
Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System.使用纳米颗粒载体系统进行大分子非侵入性递送的最新进展
Curr Pharm Des. 2017;23(3):440-453. doi: 10.2174/1381612822666161026163201.
5
Strategies for non-invasive delivery of biologics.生物制剂的非侵入性递送策略。
J Drug Target. 2012 Jul;20(6):481-501. doi: 10.3109/1061186X.2012.693499. Epub 2012 May 28.
6
Challenges to macromolecular drug delivery.大分子药物递送面临的挑战。
Biochem Soc Trans. 2007 Feb;35(Pt 1):41-3. doi: 10.1042/BST0350041.
7
Novel strategies for the buccal delivery of macromolecules.大分子经颊部给药的新策略。
Drug Dev Ind Pharm. 2014 May;40(5):579-90. doi: 10.3109/03639045.2014.892960. Epub 2014 Mar 10.
8
Protein nanoparticles for therapeutic protein delivery.用于治疗性蛋白质递送的蛋白质纳米颗粒。
Biomater Sci. 2015 Jun;3(6):787-99. doi: 10.1039/c5bm00052a. Epub 2015 May 13.
9
Nonlamellar liquid crystals: a new paradigm for the delivery of small molecules and bio-macromolecules.非层状液晶：小分子和生物大分子递送的新范例。
Ther Deliv. 2018 Sep;9(9):667-689. doi: 10.4155/tde-2018-0038.
10
Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules.用于大分子经粘膜递送的新型透明质酸基纳米载体。
Macromol Biosci. 2008 May 13;8(5):441-50. doi: 10.1002/mabi.200700190.
引用本文的文献
1
Targeted co-delivery of IL-10 and catalase for cooperative therapeutic effect on acute kidney injury.白细胞介素-10和过氧化氢酶的靶向共递送对急性肾损伤的协同治疗作用
Bioact Mater. 2025 Jun 19;52:604-622. doi: 10.1016/j.bioactmat.2025.06.020. eCollection 2025 Oct.
2
Can breakthroughs in dermal and transdermal macromolecule delivery surmount existing barriers and revolutionize future therapeutics?皮肤和透皮大分子递送方面的突破能否克服现有障碍并彻底改变未来的治疗方法？
J Transl Med. 2025 May 7;23(1):513. doi: 10.1186/s12967-025-06219-6.
3
Polymeric microneedle advancements in macromolecule drug delivery: current trends, challenges, and future perspectives.高分子药物递送中聚合物微针的进展：当前趋势、挑战及未来展望。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 17. doi: 10.1007/s00210-025-04117-8.
4
Enhanced localized pressure-mediated non-viral gene delivery.增强的局部压力介导的非病毒基因递送。
Drug Deliv Transl Res. 2025 Mar 12. doi: 10.1007/s13346-025-01827-7.
5
Nanotechnology-based Approaches for Targeted Drug Delivery to the Small Intestine: Advancements and Challenges.基于纳米技术的小肠靶向给药方法：进展与挑战
Curr Pharm Des. 2025 Feb 10. doi: 10.2174/0113816128347722250109042022.
6
Exploring lung cancer microenvironment: pathways and nanoparticle-based therapies.探索肺癌微环境：信号通路与基于纳米颗粒的疗法。
Discov Oncol. 2025 Feb 11;16(1):159. doi: 10.1007/s12672-025-01902-y.
7
Induced Pluripotent Stem Cells in Birds: Opportunities and Challenges for Science and Agriculture.鸟类中的诱导多能干细胞：科学与农业面临的机遇与挑战
Vet Sci. 2024 Dec 19;11(12):666. doi: 10.3390/vetsci11120666.
8
Advancements and challenges in brain cancer therapeutics.脑癌治疗的进展与挑战
Exploration (Beijing). 2024 May 16;4(6):20230177. doi: 10.1002/EXP.20230177. eCollection 2024 Dec.
9
Form Equals Function: Influence of Coacervate Architecture on Drug Delivery Applications.形式决定功能：凝聚体形貌对药物传递应用的影响。
ACS Biomater Sci Eng. 2024 Nov 11;10(11):6766-6789. doi: 10.1021/acsbiomaterials.4c01105. Epub 2024 Oct 18.
10
Bioactive injectable mucoadhesive thermosensitive natural polymeric hydrogels for oral bone and periodontal regeneration.用于口腔骨和牙周组织再生的具有生物活性的可注射粘膜粘附热敏天然聚合物水凝胶
Front Bioeng Biotechnol. 2024 May 28;12:1384326. doi: 10.3389/fbioe.2024.1384326. eCollection 2024.
本文引用的文献
1
Optimization of novel pentablock copolymer based composite formulation for sustained delivery of peptide/protein in the treatment of ocular diseases.基于新型五嵌段共聚物的复合制剂的优化，用于在眼部疾病治疗中持续递送肽/蛋白质。
J Microencapsul. 2016;33(2):103-13. doi: 10.3109/02652048.2015.1134685. Epub 2016 Mar 11.
2
Development of a long-acting, protein-loaded, redox-active, injectable gel formed by a polyion complex for local protein therapeutics.开发一种长效、载蛋白、氧化还原活性的聚离子复合物注射凝胶，用于局部蛋白治疗。
Biomaterials. 2016 Apr;84:210-218. doi: 10.1016/j.biomaterials.2016.01.029. Epub 2016 Jan 19.
3
Composite Nanoformulation Therapeutics for Long-Term Ocular Delivery of Macromolecules.用于大分子长期眼部递送的复合纳米制剂疗法
Mol Pharm. 2016 Sep 6;13(9):2912-22. doi: 10.1021/acs.molpharmaceut.5b00828. Epub 2016 Feb 26.
4
Formulation and Characterization of Bovine Serum Albumin-Loaded Niosome.载牛血清白蛋白脂质体的制备与表征
AAPS PharmSciTech. 2017 Jan 1;18(1):27-33. doi: 10.1208/s12249-016-0487-1. Epub 2016 Jan 27.
5
Amorphous Calcium Carbonate Based-Microparticles for Peptide Pulmonary Delivery.基于无定形碳酸钙的微球用于肽类肺部递药。
ACS Appl Mater Interfaces. 2016 Jan 20;8(2):1164-75. doi: 10.1021/acsami.5b09023. Epub 2016 Jan 5.
6
pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein delivery.用于口服递送治疗性蛋白质的pH响应和酶响应水凝胶微粒：蛋白质大小、交联密度和水凝胶降解对蛋白质递送的影响。
J Control Release. 2016 Jan 10;221:18-25. doi: 10.1016/j.jconrel.2015.11.023. Epub 2015 Dec 2.
7
Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release.奥曲肽长效凝胶微球制剂：聚合物类型对体外释放过程中肽酰化作用的影响。
Int J Pharm. 2015 Dec 30;496(2):676-88. doi: 10.1016/j.ijpharm.2015.11.002. Epub 2015 Nov 10.
8
Heparin and Vascular Endothelial Growth Factor Loaded Poly(L-lactide-co-caprolactone) Nanofiber Covered Stent-Graft for Aneurysm Treatment.载有肝素和血管内皮生长因子的聚（L-丙交酯-共-己内酯）纳米纤维覆盖的覆膜支架用于动脉瘤治疗
J Biomed Nanotechnol. 2015 Nov;11(11):1947-60. doi: 10.1166/jbn.2015.2138.
9
Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles.制备、表征及免疫学评价：负载犬细小病毒合成肽的聚乳酸-羟基乙酸共聚物纳米颗粒
J Biomed Sci. 2015 Oct 20;22:89. doi: 10.1186/s12929-015-0195-2.
10
A lipid based multi-compartmental system: Liposomes-in-double emulsion for oral vaccine delivery.一种基于脂质的多隔室系统：用于口服疫苗递送的双乳液包封脂质体。
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):15-21. doi: 10.1016/j.ejpb.2015.09.018. Epub 2015 Oct 9.
Zotero 插件